Qiu GZ - Search Results

1

Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies.

Qiu GZ, Jin MZ, Dai JX, Sun W, Feng JH, Jin WL. Qiu GZ, et al. Trends Pharmacol Sci. 2017 Aug;38(8):669-686. doi: 10.1016/j.tips.2017.05.002. Epub 2017 Jun 12. Trends Pharmacol Sci. 2017. PMID: 28602395 Review.

2

The transducible TAT-RIZ1-PR protein exerts histone methyltransferase activity and tumor-suppressive functions in human malignant meningiomas.

Ding MH, Wang Z, Jiang L, Fu HL, Gao J, Lin XB, Zhang CL, Liu ZY, Shi YF, Qiu GZ, Ma Y, Cui DX, Hu GH, Jin WL. Ding MH, et al. Among authors: qiu gz. Biomaterials. 2015 Jul;56:165-78. doi: 10.1016/j.biomaterials.2015.03.058. Epub 2015 Apr 17. Biomaterials. 2015. PMID: 25934289

3

RNA interference against TMEM97 inhibits cell proliferation, migration, and invasion in glioma cells.

Qiu G, Sun W, Zou Y, Cai Z, Wang P, Lin X, Huang J, Jiang L, Ding X, Hu G. Qiu G, et al. Tumour Biol. 2015 Sep;36(10):8231-8. doi: 10.1007/s13277-015-3552-6. Epub 2015 May 23. Tumour Biol. 2015. PMID: 26002575

4

Knockdown of TMEM45A inhibits the proliferation, migration and invasion of glioma cells.

Sun W, Qiu G, Zou Y, Cai Z, Wang P, Lin X, Huang J, Jiang L, Ding X, Hu G. Sun W, et al. Int J Clin Exp Pathol. 2015 Oct 1;8(10):12657-67. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26722455 Free PMC article.

5

Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges.

Jin WL, Mao XY, Qiu GZ. Jin WL, et al. Among authors: qiu gz. Med Res Rev. 2017 May;37(3):627-661. doi: 10.1002/med.21421. Epub 2016 Oct 24. Med Res Rev. 2017. PMID: 27775833 Review.

6

The bad seed gardener: Deubiquitinases in the cancer stem-cell signaling network and therapeutic resistance.

Qiu GZ, Sun W, Jin MZ, Lin J, Lu PG, Jin WL. Qiu GZ, et al. Pharmacol Ther. 2017 Apr;172:127-138. doi: 10.1016/j.pharmthera.2016.12.003. Epub 2016 Dec 3. Pharmacol Ther. 2017. PMID: 27919796 Review.

7

Overexpression of ubiquitin specific proteases 44 promotes the malignancy of glioma by stabilizing tumor-promoter securin.

Zou Y, Qiu G, Jiang L, Cai Z, Sun W, Hu H, Lu C, Jin W, Hu G. Zou Y, et al. Oncotarget. 2017 Mar 22;8(35):58231-58246. doi: 10.18632/oncotarget.16447. eCollection 2017 Aug 29. Oncotarget. 2017. PMID: 28938551 Free PMC article.

8

Organoids: An intermediate modeling platform in precision oncology.

Jin MZ, Han RR, Qiu GZ, Ju XC, Lou G, Jin WL. Jin MZ, et al. Among authors: qiu gz. Cancer Lett. 2018 Feb 1;414:174-180. doi: 10.1016/j.canlet.2017.11.021. Epub 2017 Nov 22. Cancer Lett. 2018. PMID: 29174804 Review.

9

Ubiquitin-specific protease 22 acts as an oncoprotein to maintain glioma malignancy through deubiquitinating B cell-specific Moloney murine leukemia virus integration site 1 for stabilization.

Qiu GZ, Mao XY, Ma Y, Gao XC, Wang Z, Jin MZ, Sun W, Zou YX, Lin J, Fu HL, Jin WL. Qiu GZ, et al. Cancer Sci. 2018 Jul;109(7):2199-2210. doi: 10.1111/cas.13646. Epub 2018 Jun 28. Cancer Sci. 2018. PMID: 29788550 Free PMC article.

10

Hypoxia-induced USP22-BMI1 axis promotes the stemness and malignancy of glioma stem cells via regulation of HIF-1α.

Qiu GZ, Liu Q, Wang XG, Xu GZ, Zhao T, Lou MQ. Qiu GZ, et al. Life Sci. 2020 Apr 15;247:117438. doi: 10.1016/j.lfs.2020.117438. Epub 2020 Feb 15. Life Sci. 2020. PMID: 32070708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters